Catalyst Wire Dossier Catalyst Wire Dossier

Hetrombopag

hetrombopag · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for Hetrombopag, covering 2015-03-31 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors [Phase 2]

See pricing